THE COMPOUND
Sunday brief · since 2026
The Early Read · operator-grade peptide briefs

The peptide your Discord won't cover for 6 months.

One emerging compound every Sunday. Mechanism class, half-life, primary literature anchor, what the community will get wrong. Before consensus forms. Free PDF: the first 4 Early Reads in your inbox now. Then a 5-minute brief every Sunday at 9 AM ET. No dosing on the public side. Ever.

Free forever · Unsubscribe with one reply · Beehiiv-hosted, never sold
In the Vault · 4 Early Reads
  1. Selank + Semax — the Russian-Academy cognition stack with a thin Tier 2 layer Western literature ignores
  2. Retatrutide bloat — the contrarian read: it's a titration artifact, not the molecule
  3. Kisspeptin-10 — Phase 2 reproductive-axis data + the longevity-adjacency overreach
  4. GHK-Cu (parenteral) — copper-tripeptide skin science with an injection community ahead of the data
Delivered as one PDF · 30 seconds after signup
Founded by an operator Tier 1 RCT → Tier 4 n=1 No dosing on the public side One email per week
Colby Watkins, founder of The Compound Brief

I'm Colby. I run heroxbio.com — RUO peptide vendor. I started The Compound because I got sick of reading peptide takes that couldn't tell the difference between a Tier 1 trial and an n=1 Discord post.

The Compound is the read I wish I had when I started buying peptides RUO. Sunday morning, 9 AM ET. The framework is the product. The vendor is disclosed.

— Colby Watkins

This is for / this is not for

Built for

Founder-operators already buying peptides RUO who want a literature-grade read on what's worth pinning.

Operators who'd rather know how to read a COA than which Discord swears by which protocol.

Readers who want the news decoded against tiered evidence — not whatever the algorithm pushed up that week.

Not for

Pre-medical readers looking for clinical advice. (See your physician.)

Anyone hoping for a protocol or dosing recipe. None on the public side. Ever.

Readers who want hype. The brief is mechanism, half-life, and what the literature actually shows.

What you get

The Conflict Test

Yes, I run heroxbio.com — an RUO peptide vendor. Disclosed under every issue.

The test: when an issue covers a compound heroxbio sells, the language is the same as when it doesn't. The framework is the product, not the vendor.

If a Compound issue ever pitches you a heroxbio compound — call it out by reply. The brief dies the day you can't trust the read.

FAQ

Is this medical advice?
No. Research use only. Compounds discussed are sold for research purposes; nothing is a recommendation to use them on humans or animals.
How often do you email?
Once per week. Sunday, 9 AM ET. Plus a 3-email welcome over the first 72 hours after you sign up. Then weekly only.
What's the actual catch?
I run heroxbio.com — an RUO peptide vendor. Disclosed under every issue. The newsletter is free. heroxbio is how this gets paid for. The framework is the same whether or not heroxbio sells the compound covered.
Will you sell my email?
No. Beehiiv hosts the list. I never share, sell, or rent. Reply STOP at any time and you're off permanently.
Is dosing in the issues?
No. No dosing on the public side. RUO context only. Operator-grade reads on mechanism, half-life, and the literature.
What's the next issue?
Sunday 5/11 — The 14 Peptides Decoded — Part 1: The List. The reconstruction of RFK's "14 banned peptides" reference, decoded compound by compound. Mechanism class, half-life, status, why it matters.

One read and you'll know.

If you've ever paid $19 for a peptide Substack and gotten a recipe blog — this is the read built against that. If you trust no one in this category and want to verify yourself — the framework is portable. Take the COA-read, leave the vendor.

30 seconds, then I'm out of your way until Sunday
Other free tools
Reconstitution Calculator
17 compounds. mg → mcg per IU. Half-life graph. Cost-per-mg compare. Mobile-first. No signup.
Open the calculator →
Compound Index
55 compounds, evidence-tiered. Half-life, MW, cost-per-mg, what's contested per row.
Browse the index →